Acceleron Pharma (United States)
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Acceleron Pharma (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
41%
Total
Publications
440
Total Open
Publications
181
Total
Citations
18K
Open Access
Percentage
41%
Total
Publications
440
Total Open
Publications
181
Total
Citations
18K
Breakdown
Publisher Open
11%
Both
20%
Other Platform Open
9%
Closed
60%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 38%
50
Hybrid 31%
40
No Guarantees 31%
41
Other Platform Open
Domain 82%
101
Institution 41%
51
Other Internet 7%
9
Preprint 7%
8
Public 2%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 103 |
doaj.org OAI-PMH Repository | Institution | 23 |
DOI | Other Internet | 9 |
Harvard University | Institution | 5 |
bioRxiv | Preprint | 5 |
University of Groningen | Institution | 4 |
King's College London | Institution | 4 |
University of Modena and Reggio Emilia | Institution | 3 |
University of Milan | Institution | 3 |
University of Florence | Institution | 3 |